CORT · CORCEPT THERAPEUTICS INC
← all insidersPharmaceutical Preparations · Listed on Nasdaq
Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON
Open-market trades61
Distinct insiders9
Bought$0
Sold$59.73M
Net flow$-59.73M
Recent filings
How to read this
- Filed
- Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
- Ticker
- The issuer's stock symbol. Select it to open that company's insider-activity page.
- Issuer
- The company whose shares were traded.
- Sector
- The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
- Insider
- The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
- Role
- The insider's relationship to the company: director, officer, or 10% owner.
- Code
- SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
- Side
- Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
- 10b5-1
- Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
- Shares
- Number of shares in this transaction.
- Price
- Reported price per share. Blank for grants, gifts, and other trades with no stated price.
- Value
- Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
- Owned after
- Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
- Own Δ
- How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
- Co. Δ
- Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
- D/I
- Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
- Lag
- Days from the trade date to the filing date (Form 4 is due within 2 business days).
Transaction codes
Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.
- P
- Open market or private purchase of non-derivative or derivative security
- S
- Open market or private sale of non-derivative or derivative security
- A
- Grant, award or other acquisition pursuant to Rule 16b-3(d)
- D
- Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
- F
- Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
- M
- Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
- G
- Bona fide gift
- C
- Conversion of derivative security
- X
- Exercise of in-the-money or at-the-money derivative security
- J
- Other acquisition or disposition (describe transaction)
| FiledDate the Form 4 was filed with the SEC (due within 2 business days of the trade). | Insider | Role | CodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S). | SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼). | Shares | PriceReported price per share. Blank for trades with no stated price. | Value ↓Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ). | Owned afterShares the insider held (directly or indirectly) immediately after this trade. | Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing. | Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable. | Link to SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 | MAHONEY DAVID L | Director | S | ▼ sell10b5-1 | 91,1670 | $118.24 | $10.78M | 1,140,994 | −7% | −0.08% (now 1.1%) | filing |
| 2026-05-29 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 54,5750 | $65.37 | $3.57M | 29,402 | −65% | −0.05% (now 0.03%) | filing |
| 2026-08-28 | Park Kimberly | Director | S | ▼ sell | 26,6850 | $122.55 | $3.27M | 0 | −100% | −0.02% (now 0%) | filing |
| 2026-08-27 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 25,0850 | $125.47 | $3.15M | 15,625 | −62% | −0.02% (now 0.01%) | filing |
| 2026-06-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 40,0000 | $70.00 | $2.80M | 15,257 | −72% | −0.04% (now 0.01%) | filing |
| 2026-09-03 | Vieira Roberto Wandenkolk | Officer (President, Oncology) | S | ▼ sell10b5-1 | 23,7700 | $110.70 | $2.63M | 15,205 | −61% | −0.02% (now 0.01%) | filing |
| 2026-09-03 | Vieira Roberto Wandenkolk | Officer (President, Oncology) | S | ▼ sell10b5-1 | 23,6000 | $109.35 | $2.58M | 38,975 | −38% | −0.02% (now 0.04%) | filing |
| 2026-07-17 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 28,4600 | $87.89 | $2.50M | 19,751 | −59% | −0.03% (now 0.02%) | filing |
| 2026-08-05 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 20,3050 | $114.70 | $2.33M | 9,755 | −68% | −0.02% (now <0.01%) | filing |
| 2026-05-05 | BELANOFF JOSEPH K | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 40,0000 | $50.10 | $2.00M | 2,878,326 | −1% | −0.04% (now 2.7%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | M | ▲ buy10b5-1 | 80,0000 | $23.06 | $1.84M | 96,130 | 6.0× | +0.07% (now 0.09%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 15,4770 | $114.96 | $1.78M | 59,595 | −21% | −0.01% (now 0.06%) | filing |
| 2026-07-08 | Guyer William | Officer (Chief Development Officer) | S | ▼ sell10b5-1 | 19,0480 | $93.11 | $1.77M | 4,937 | −79% | −0.02% (now <0.01%) | filing |
| 2026-06-18 | MAHONEY DAVID L | Director | S | ▼ sell | 20,0000 | $84.53 | $1.69M | 26,147 | −43% | −0.02% (now 0.02%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 14,2220 | $115.87 | $1.65M | 45,373 | −24% | −0.01% (now 0.04%) | filing |
| 2026-06-17 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 19,4830 | $81.81 | $1.59M | 16,132 | −55% | −0.02% (now 0.01%) | filing |
| 2026-06-03 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 21,0690 | $70.11 | $1.48M | 12,908 | −62% | −0.02% (now 0.01%) | filing |
| 2026-06-04 | Guyer William | Officer (Chief Development Officer) | S | ▼ sell10b5-1 | 20,0000 | $70.60 | $1.41M | 3,985 | −83% | −0.02% (now <0.01%) | filing |
| 2026-05-29 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 20,4250 | $66.16 | $1.35M | 8,977 | −69% | −0.02% (now <0.01%) | filing |
| 2026-09-03 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 11,7300 | $113.94 | $1.34M | 23,025 | −34% | −0.01% (now 0.02%) | filing |
| 2026-03-27 | BELANOFF JOSEPH K | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 26,1980 | $50.07 | $1.31M | 2,918,326 | −0.9% | −0.02% (now 2.7%) | filing |
| 2026-08-12 | Guyer William | Officer (Chief Development Officer) | S | ▼ sell10b5-1 | 11,5300 | $113.18 | $1.30M | 8,755 | −57% | −0.01% (now <0.01%) | filing |
| 2026-09-03 | Vieira Roberto Wandenkolk | Officer (President, Oncology) | M | ▲ buy10b5-1 | 58,3330 | $21.63 | $1.26M | 62,575 | 15× | +0.05% (now 0.06%) | filing |
| 2026-09-03 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 10,9890 | $114.71 | $1.26M | 12,036 | −48% | −0.01% (now 0.01%) | filing |
| 2026-08-18 | Robb Gary Charles | Officer (Chief Business Officer) | S | ▼ sell | 10,0000 | $116.26 | $1.16M | 39,716 | −20% | −<0.01% (now 0.04%) | filing |
| 2026-05-07 | Guyer William | Officer (Chief Development Officer) | S | ▼ sell10b5-1 | 20,0000 | $51.83 | $1.04M | 2,231 | −90% | −0.02% (now <0.01%) | filing |
| 2026-07-06 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 11,1750 | $89.31 | $998.0K | 9,755 | −53% | −0.01% (now <0.01%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 8,2670 | $117.93 | $975.0K | 30,017 | −22% | −<0.01% (now 0.03%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 8,1030 | $119.95 | $971.9K | 17,131 | −32% | −<0.01% (now 0.02%) | filing |
| 2026-07-06 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 11,0240 | $87.33 | $962.8K | 23,731 | −32% | −0.01% (now 0.02%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 8,9560 | $106.96 | $957.9K | 82,974 | −10% | −<0.01% (now 0.08%) | filing |
| 2026-06-17 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 11,0810 | $80.94 | $896.9K | 35,615 | −24% | −0.01% (now 0.03%) | filing |
| 2026-06-02 | BELANOFF JOSEPH K | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 12,8370 | $69.74 | $895.3K | 2,565,489 | −0.5% | −0.01% (now 2.4%) | filing |
| 2026-08-20 | MAHONEY DAVID L | Director | S | ▼ sell10b5-1 | 7,0550 | $118.88 | $838.7K | 1,133,939 | −0.6% | −<0.01% (now 1.0%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 7,0890 | $116.96 | $829.1K | 38,284 | −16% | −<0.01% (now 0.04%) | filing |
| 2026-04-08 | Guyer William | Officer (Chief Development Officer) | S | ▼ sell10b5-1 | 20,0000 | $40.97 | $819.4K | 2,231 | −90% | −0.02% (now <0.01%) | filing |
| 2026-06-17 | Mokari Atabak | Officer (Chief Financial Officer) | M | ▲ buy10b5-1 | 40,0000 | $19.26 | $770.4K | 56,130 | 3.5× | +0.04% (now 0.05%) | filing |
| 2026-06-03 | Mokari Atabak | Officer (Chief Financial Officer) | M | ▲ buy10b5-1 | 40,0000 | $19.26 | $770.4K | 55,257 | 3.6× | +0.04% (now 0.05%) | filing |
| 2026-06-17 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 9,4340 | $80.02 | $754.9K | 46,696 | −17% | −<0.01% (now 0.04%) | filing |
| 2026-08-27 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 5,8700 | $126.06 | $740.0K | 9,755 | −38% | −<0.01% (now <0.01%) | filing |
| 2026-07-17 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 7,9190 | $86.78 | $687.2K | 48,211 | −14% | −<0.01% (now 0.04%) | filing |
| 2026-09-03 | Vieira Roberto Wandenkolk | Officer (President, Oncology) | S | ▼ sell10b5-1 | 5,6210 | $114.58 | $644.0K | 5,467 | −51% | −<0.01% (now <0.01%) | filing |
| 2026-05-29 | Maduck Sean | Officer (See Remarks) | M | ▲ buy10b5-1 | 75,0000 | $8.27 | $620.3K | 83,977 | 9.4× | +0.07% (now 0.08%) | filing |
| 2026-08-20 | MAHONEY DAVID L | Director | S | ▼ sell10b5-1 | 4,9840 | $117.47 | $585.5K | 1,232,161 | −0.4% | −<0.01% (now 1.1%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 4,7830 | $118.73 | $567.9K | 25,234 | −16% | −<0.01% (now 0.02%) | filing |
| 2026-07-17 | Mokari Atabak | Officer (Chief Financial Officer) | M | ▲ buy10b5-1 | 24,1670 | $23.06 | $557.3K | 56,130 | +76% | +0.02% (now 0.05%) | filing |
| 2026-08-12 | Guyer William | Officer (Chief Development Officer) | S | ▼ sell10b5-1 | 4,7700 | $114.04 | $544.0K | 3,985 | −54% | −<0.01% (now <0.01%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 4,7000 | $113.18 | $531.9K | 75,072 | −6% | −<0.01% (now 0.07%) | filing |
| 2026-08-18 | WILSON JAMES N | Director | S | ▼ sell10b5-1 | 4,6680 | $111.44 | $520.2K | 1,076,822 | −0.4% | −<0.01% (now 1.00%) | filing |
| 2026-06-18 | WILSON JAMES N | Director | S | ▼ sell10b5-1 | 5,8230 | $83.57 | $486.6K | 1,094,543 | −0.5% | −<0.01% (now 1.0%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 4,2000 | $105.54 | $443.2K | 91,930 | −4% | −<0.01% (now 0.09%) | filing |
| 2026-07-08 | Guyer William | Officer (Chief Development Officer) | M | ▲ buy10b5-1 | 20,0000 | $21.65 | $433.0K | 23,985 | 6.0× | +0.02% (now 0.02%) | filing |
| 2026-06-04 | Guyer William | Officer (Chief Development Officer) | M | ▲ buy10b5-1 | 20,0000 | $21.65 | $433.0K | 23,985 | 6.0× | +0.02% (now 0.02%) | filing |
| 2026-05-07 | Guyer William | Officer (Chief Development Officer) | M | ▲ buy10b5-1 | 20,0000 | $21.65 | $433.0K | 22,231 | 10.0× | +0.02% (now 0.02%) | filing |
| 2026-04-08 | Guyer William | Officer (Chief Development Officer) | M | ▲ buy10b5-1 | 20,0000 | $21.65 | $433.0K | 22,231 | 10.0× | +0.02% (now 0.02%) | filing |
| 2026-03-24 | Guyer William | Officer (Chief Development Officer) | S | ▼ sell10b5-1 | 11,7670 | $36.01 | $423.7K | 2,231 | −84% | −0.01% (now <0.01%) | filing |
| 2026-08-18 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 3,6640 | $114.49 | $419.5K | 9,755 | −27% | −<0.01% (now <0.01%) | filing |
| 2026-08-06 | Guyer William | Officer (Chief Development Officer) | S | ▼ sell10b5-1 | 3,7000 | $113.12 | $418.6K | 3,985 | −48% | −<0.01% (now <0.01%) | filing |
| 2026-08-28 | Park Kimberly | Director | F | ▼ sell | 3,3150 | $122.09 | $404.7K | 26,685 | −11% | −<0.01% (now 0.02%) | filing |
| 2026-08-28 | Park Kimberly | Director | M | ▲ buy | 30,0000 | $13.49 | $404.7K | 30,000 | new | +0.03% (now 0.03%) | filing |
| 2026-08-12 | Guyer William | Officer (Chief Development Officer) | M | ▲ buy10b5-1 | 16,3000 | $21.65 | $352.9K | 20,285 | 5.1× | +0.02% (now 0.02%) | filing |
| 2026-08-27 | Maduck Sean | Officer (See Remarks) | M | ▲ buy10b5-1 | 30,9550 | $11.35 | $351.3K | 40,710 | 4.2× | +0.03% (now 0.04%) | filing |
| 2026-07-17 | WILSON JAMES N | Director | S | ▼ sell10b5-1 | 3,9690 | $87.74 | $348.2K | 1,089,495 | −0.4% | −<0.01% (now 1.0%) | filing |
| 2026-06-18 | WILSON JAMES N | Director | S | ▼ sell10b5-1 | 4,1770 | $82.69 | $345.4K | 1,100,366 | −0.4% | −<0.01% (now 1.0%) | filing |
| 2026-08-18 | WILSON JAMES N | Director | S | ▼ sell10b5-1 | 3,0530 | $110.49 | $337.3K | 1,081,490 | −0.3% | −<0.01% (now 1.0%) | filing |
| 2026-05-29 | Lyon Joseph Douglas | Officer (See Remarks) | S | ▼ sell | 5,0000 | $65.00 | $325.0K | 6,230 | −45% | −<0.01% (now <0.01%) | filing |
| 2026-07-17 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 3,5200 | $88.30 | $310.8K | 16,231 | −18% | −<0.01% (now 0.02%) | filing |
| 2026-07-17 | Mokari Atabak | Officer (Chief Financial Officer) | M | ▲ buy10b5-1 | 15,8330 | $19.26 | $304.9K | 31,963 | +98% | +0.01% (now 0.03%) | filing |
| 2026-06-03 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 3,9310 | $70.75 | $278.1K | 8,977 | −30% | −<0.01% (now <0.01%) | filing |
| 2026-07-17 | WILSON JAMES N | Director | S | ▼ sell10b5-1 | 2,9740 | $88.81 | $264.1K | 1,086,521 | −0.3% | −<0.01% (now 1.0%) | filing |
| 2026-09-03 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 2,2810 | $115.61 | $263.7K | 9,755 | −19% | −<0.01% (now <0.01%) | filing |
| 2026-08-18 | WILSON JAMES N | Director | S | ▼ sell10b5-1 | 2,2790 | $112.64 | $256.7K | 1,074,543 | −0.2% | −<0.01% (now 0.99%) | filing |
| 2026-03-24 | Guyer William | Officer (Chief Development Officer) | M | ▲ buy10b5-1 | 11,7670 | $21.65 | $254.8K | 13,998 | 6.3× | +0.01% (now 0.01%) | filing |
| 2026-07-06 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 2,8010 | $88.51 | $247.9K | 20,930 | −12% | −<0.01% (now 0.02%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 2,2020 | $110.03 | $242.3K | 80,372 | −3% | −<0.01% (now 0.07%) | filing |
| 2026-09-03 | Maduck Sean | Officer (See Remarks) | M | ▲ buy10b5-1 | 25,0000 | $8.27 | $206.8K | 34,755 | 3.6× | +0.02% (now 0.03%) | filing |
| 2026-07-06 | Maduck Sean | Officer (See Remarks) | M | ▲ buy10b5-1 | 25,0000 | $8.27 | $206.8K | 34,755 | 3.6× | +0.02% (now 0.03%) | filing |
| 2026-06-03 | Maduck Sean | Officer (See Remarks) | M | ▲ buy10b5-1 | 25,0000 | $8.27 | $206.8K | 33,977 | 3.8× | +0.02% (now 0.03%) | filing |
| 2026-09-03 | Vieira Roberto Wandenkolk | Officer (President, Oncology) | S | ▼ sell10b5-1 | 1,6060 | $113.72 | $182.6K | 11,088 | −13% | −<0.01% (now 0.01%) | filing |
| 2026-07-17 | WILSON JAMES N | Director | S | ▼ sell10b5-1 | 1,9780 | $89.49 | $177.0K | 1,084,543 | −0.2% | −<0.01% (now 1.0%) | filing |
| 2026-08-05 | Lyon Joseph Douglas | Officer (See Remarks) | S | ▼ sell | 1,5400 | $114.16 | $175.8K | 5,495 | −22% | −<0.01% (now <0.01%) | filing |
| 2026-09-03 | Vieira Roberto Wandenkolk | Officer (President, Oncology) | S | ▼ sell10b5-1 | 1,5370 | $111.37 | $171.2K | 13,668 | −10% | −<0.01% (now 0.01%) | filing |
| 2026-08-05 | Maduck Sean | Officer (See Remarks) | M | ▲ buy10b5-1 | 20,3050 | $8.27 | $167.9K | 30,060 | 3.1× | +0.02% (now 0.03%) | filing |
| 2026-09-03 | Vieira Roberto Wandenkolk | Officer (President, Oncology) | S | ▼ sell10b5-1 | 1,2250 | $115.44 | $141.4K | 4,242 | −22% | −<0.01% (now <0.01%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 1,0010 | $120.67 | $120.8K | 16,130 | −6% | −<0.01% (now 0.01%) | filing |
| 2026-08-12 | Maduck Sean | Officer (See Remarks) | S | ▼ sell10b5-1 | 1,0310 | $114.52 | $118.1K | 9,755 | −10% | −<0.01% (now <0.01%) | filing |
| 2026-09-03 | Vieira Roberto Wandenkolk | Officer (President, Oncology) | S | ▼ sell10b5-1 | 9740 | $112.40 | $109.5K | 12,694 | −7% | −<0.01% (now 0.01%) | filing |
| 2026-07-17 | WILSON JAMES N | Director | S | ▼ sell10b5-1 | 1,0790 | $86.78 | $93.6K | 1,093,464 | −<0.1% | −<0.01% (now 1.0%) | filing |
| 2026-07-08 | Guyer William | Officer (Chief Development Officer) | S | ▼ sell10b5-1 | 9520 | $93.54 | $89.0K | 3,985 | −19% | −<0.01% (now <0.01%) | filing |
| 2026-08-06 | Guyer William | Officer (Chief Development Officer) | M | ▲ buy10b5-1 | 3,7000 | $21.65 | $80.1K | 7,685 | +93% | +<0.01% (now <0.01%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 6000 | $110.95 | $66.6K | 79,772 | −0.7% | −<0.01% (now 0.07%) | filing |
| 2026-06-03 | Guyer William | Officer (Chief Development Officer) | A | ▲ buy | 8770 | $70.44 | $61.8K | 3,108 | +39% | +<0.01% (now <0.01%) | filing |
| 2026-06-03 | Robb Gary Charles | Officer (Chief Business Officer) | A | ▲ buy | 7760 | $70.44 | $54.7K | 25,263 | +3% | +<0.01% (now 0.02%) | filing |
| 2026-08-20 | MAHONEY DAVID L | Director | S | ▼ sell10b5-1 | 4000 | $119.64 | $47.9K | 1,133,539 | −<0.1% | −<0.01% (now 1.0%) | filing |
| 2026-06-03 | Mokari Atabak | Officer (Chief Financial Officer) | A | ▲ buy10b5-1 | 6340 | $70.44 | $44.7K | 15,891 | +4% | +<0.01% (now 0.01%) | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 4000 | $108.46 | $43.4K | 82,574 | −0.5% | −<0.01% (now 0.08%) | filing |
| 2026-06-03 | Maduck Sean | Officer (See Remarks) | A | ▲ buy10b5-1 | 6150 | $70.44 | $43.3K | 9,592 | +7% | +<0.01% (now <0.01%) | filing |
| 2026-06-03 | Lyon Joseph Douglas | Officer (See Remarks) | A | ▲ buy | 5370 | $70.44 | $37.8K | 6,767 | +9% | +<0.01% (now <0.01%) | filing |
| 2026-06-03 | Maduck Sean | Officer (See Remarks) | F | ▼ sell10b5-1 | 4520 | $70.44 | $31.8K | 9,755 | −4% | −<0.01% (now <0.01%) | filing |
| 2026-08-18 | Maduck Sean | Officer (See Remarks) | M | ▲ buy10b5-1 | 3,6640 | $8.27 | $30.3K | 13,419 | +38% | +<0.01% (now 0.01%) | filing |
| 2026-06-03 | Mokari Atabak | Officer (Chief Financial Officer) | F | ▼ sell10b5-1 | 3950 | $70.44 | $27.8K | 16,130 | −2% | −<0.01% (now 0.01%) | filing |
| 2026-06-03 | Robb Gary Charles | Officer (Chief Business Officer) | F | ▼ sell | 3580 | $70.44 | $25.2K | 25,681 | −1% | −<0.01% (now 0.02%) | filing |
| 2026-06-03 | Lyon Joseph Douglas | Officer (See Remarks) | F | ▼ sell | 2690 | $70.44 | $18.9K | 7,035 | −4% | −<0.01% (now <0.01%) | filing |
| 2026-09-03 | Guyer William | Officer (Chief Development Officer) | A | ▲ buy | 1640 | $113.38 | $18.6K | 4,149 | +4% | +<0.01% (now <0.01%) | filing |
| 2026-09-03 | Robb Gary Charles | Officer (Chief Business Officer) | A | ▲ buy | 1640 | $113.38 | $18.6K | 13,590 | +1% | +<0.01% (now 0.01%) | filing |
| 2026-09-03 | Maduck Sean | Officer (See Remarks) | A | ▲ buy10b5-1 | 1500 | $113.38 | $17.0K | 9,905 | +2% | +<0.01% (now <0.01%) | filing |
| 2026-09-03 | Mokari Atabak | Officer (Chief Financial Officer) | A | ▲ buy | 1380 | $113.38 | $15.6K | 16,268 | +0.9% | +<0.01% (now 0.02%) | filing |
| 2026-09-03 | Vieira Roberto Wandenkolk | Officer (President, Oncology) | A | ▲ buy10b5-1 | 1380 | $113.38 | $15.6K | 4,206 | +3% | +<0.01% (now <0.01%) | filing |
| 2026-09-03 | Lyon Joseph Douglas | Officer (See Remarks) | A | ▲ buy | 1300 | $113.38 | $14.7K | 5,625 | +2% | +<0.01% (now <0.01%) | filing |
| 2026-09-03 | Maduck Sean | Officer (See Remarks) | F | ▼ sell10b5-1 | 1170 | $113.38 | $13.3K | 9,938 | −1% | −<0.01% (now <0.01%) | filing |
| 2026-09-03 | Mokari Atabak | Officer (Chief Financial Officer) | F | ▼ sell | 1020 | $113.38 | $11.6K | 16,304 | −0.6% | −<0.01% (now 0.02%) | filing |
| 2026-09-03 | Vieira Roberto Wandenkolk | Officer (President, Oncology) | F | ▼ sell10b5-1 | 1020 | $113.38 | $11.6K | 4,242 | −2% | −<0.01% (now <0.01%) | filing |
| 2026-09-03 | Robb Gary Charles | Officer (Chief Business Officer) | F | ▼ sell | 910 | $113.38 | $10.3K | 13,663 | −0.7% | −<0.01% (now 0.01%) | filing |
| 2026-07-17 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 1010 | $89.43 | $9.0K | 16,130 | −0.6% | −<0.01% (now 0.01%) | filing |
| 2026-08-12 | Maduck Sean | Officer (See Remarks) | M | ▲ buy10b5-1 | 1,0310 | $8.27 | $8.5K | 10,786 | +11% | +<0.01% (now <0.01%) | filing |
| 2026-09-03 | Lyon Joseph Douglas | Officer (See Remarks) | F | ▼ sell | 720 | $113.38 | $8.2K | 5,683 | −1% | −<0.01% (now <0.01%) | filing |
| 2026-06-17 | Mokari Atabak | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 20 | $82.45 | $165 | 16,130 | −<0.1% | −<0.01% (now 0.01%) | filing |
| 2026-09-03 | Guyer William | Officer (Chief Development Officer) | A | ▲ buy | 1640 | — | — | 4,313 | +4% | +<0.01% (now <0.01%) | filing |
| 2026-09-03 | Maduck Sean | Officer (See Remarks) | A | ▲ buy10b5-1 | 1500 | — | — | 10,055 | +2% | +<0.01% (now <0.01%) | filing |
| 2026-09-03 | Maduck Sean | Officer (See Remarks) | M | ▼ sell10b5-1 | 25,000→ 25,000 Common Stock | — | — | 66,986 | — | — | filing |
| 2026-09-03 | Mokari Atabak | Officer (Chief Financial Officer) | A | ▲ buy | 1380 | — | — | 16,406 | +0.8% | +<0.01% (now 0.02%) | filing |
| 2026-09-03 | Robb Gary Charles | Officer (Chief Business Officer) | A | ▲ buy | 1640 | — | — | 13,754 | +1% | +<0.01% (now 0.01%) | filing |
| 2026-09-03 | Vieira Roberto Wandenkolk | Officer (President, Oncology) | A | ▲ buy10b5-1 | 1380 | — | — | 4,344 | +3% | +<0.01% (now <0.01%) | filing |
| 2026-09-03 | Vieira Roberto Wandenkolk | Officer (President, Oncology) | M | ▼ sell10b5-1 | 58,333→ 58,333 Common Stock | — | — | 141,667 | — | — | filing |
| 2026-09-03 | Lyon Joseph Douglas | Officer (See Remarks) | A | ▲ buy | 1300 | — | — | 5,755 | +2% | +<0.01% (now <0.01%) | filing |
| 2026-08-28 | Park Kimberly | Director | M | ▼ sell | 30,000→ 30,000 Common Stock | — | — | 30,000 | — | — | filing |
| 2026-08-27 | Maduck Sean | Officer (See Remarks) | M | ▼ sell10b5-1 | 30,955→ 30,955 Common Stock | — | — | 169,045 | — | — | filing |
| 2026-08-18 | Maduck Sean | Officer (See Remarks) | M | ▼ sell10b5-1 | 3,664→ 3,664 Common Stock | — | — | 91,986 | — | — | filing |
| 2026-08-18 | Robb Gary Charles | Officer (Chief Business Officer) | G | ▼ sell | 1250 | — | — | 13,426 | −0.9% | −<0.01% (now 0.01%) | filing |
| 2026-08-14 | Robb Gary Charles | Officer (Chief Business Officer) | G | ▼ sell | 11,5300 | — | — | 13,551 | −46% | −0.01% (now 0.01%) | filing |
| 2026-08-14 | Robb Gary Charles | Officer (Chief Business Officer) | G | ▲ buy | 3,0000 | — | — | 15,571 | +24% | +<0.01% (now 0.01%) | filing |
| 2026-08-14 | Robb Gary Charles | Officer (Chief Business Officer) | G | ▲ buy | 3,0000 | — | — | 15,571 | +24% | +<0.01% (now 0.01%) | filing |
| 2026-08-12 | Maduck Sean | Officer (See Remarks) | M | ▼ sell10b5-1 | 1,031→ 1,031 Common Stock | — | — | 95,650 | — | — | filing |
| 2026-08-12 | Guyer William | Officer (Chief Development Officer) | M | ▼ sell10b5-1 | 16,300→ 16,300 Common Stock | — | — | 110,000 | — | — | filing |
| 2026-08-06 | Guyer William | Officer (Chief Development Officer) | M | ▼ sell10b5-1 | 3,700→ 3,700 Common Stock | — | — | 126,300 | — | — | filing |
| 2026-08-05 | Maduck Sean | Officer (See Remarks) | M | ▼ sell10b5-1 | 20,305→ 20,305 Common Stock | — | — | 96,681 | — | — | filing |
| 2026-08-03 | Mokari Atabak | Officer (Chief Financial Officer) | M | ▼ sell10b5-1 | 80,000→ 80,000 Common Stock | — | — | 95,833 | — | — | filing |
| 2026-07-17 | Mokari Atabak | Officer (Chief Financial Officer) | M | ▼ sell10b5-1 | 15,833→ 15,833 Common Stock | — | — | 4,167 | — | — | filing |
| 2026-07-17 | Mokari Atabak | Officer (Chief Financial Officer) | M | ▼ sell10b5-1 | 24,167→ 24,167 Common Stock | — | — | 175,833 | — | — | filing |
| 2026-07-08 | Robb Gary Charles | Officer (Chief Business Officer) | G | ▼ sell | 6000 | — | — | 25,081 | −2% | −<0.01% (now 0.02%) | filing |
| 2026-07-08 | Guyer William | Officer (Chief Development Officer) | M | ▼ sell10b5-1 | 20,000→ 20,000 Common Stock | — | — | 130,000 | — | — | filing |
| 2026-07-06 | Maduck Sean | Officer (See Remarks) | M | ▼ sell10b5-1 | 25,000→ 25,000 Common Stock | — | — | 116,986 | — | — | filing |
| 2026-06-17 | Mokari Atabak | Officer (Chief Financial Officer) | M | ▼ sell10b5-1 | 40,000→ 40,000 Common Stock | — | — | 20,000 | — | — | filing |
| 2026-06-04 | Guyer William | Officer (Chief Development Officer) | M | ▼ sell10b5-1 | 20,000→ 20,000 Common Stock | — | — | 150,000 | — | — | filing |
| 2026-06-03 | Robb Gary Charles | Officer (Chief Business Officer) | A | ▲ buy | 7760 | — | — | 26,039 | +3% | +<0.01% (now 0.02%) | filing |
| 2026-06-03 | Mokari Atabak | Officer (Chief Financial Officer) | A | ▲ buy10b5-1 | 6340 | — | — | 16,525 | +4% | +<0.01% (now 0.02%) | filing |
| 2026-06-03 | Mokari Atabak | Officer (Chief Financial Officer) | M | ▼ sell10b5-1 | 40,000→ 40,000 Common Stock | — | — | 60,000 | — | — | filing |
| 2026-06-03 | Maduck Sean | Officer (See Remarks) | A | ▲ buy10b5-1 | 6150 | — | — | 10,207 | +6% | +<0.01% (now <0.01%) | filing |
| 2026-06-03 | Maduck Sean | Officer (See Remarks) | M | ▼ sell10b5-1 | 25,000→ 25,000 Common Stock | — | — | 141,986 | — | — | filing |
| 2026-06-03 | Guyer William | Officer (Chief Development Officer) | A | ▲ buy | 8770 | — | — | 3,985 | +28% | +<0.01% (now <0.01%) | filing |
| 2026-06-03 | Lyon Joseph Douglas | Officer (See Remarks) | A | ▲ buy | 5370 | — | — | 7,304 | +8% | +<0.01% (now <0.01%) | filing |
| 2026-06-02 | BELANOFF JOSEPH K | Director, Officer (Chief Executive Officer) | G | ▼ sell10b5-1 | 300,0000 | — | — | 2,578,326 | −10% | −0.28% (now 2.4%) | filing |
| 2026-06-02 | BELANOFF JOSEPH K | Director, Officer (Chief Executive Officer) | G | ▲ buy10b5-1 | 150,0000 | — | — | 150,000 | new | +0.14% (now 0.14%) | filing |
| 2026-06-02 | BELANOFF JOSEPH K | Director, Officer (Chief Executive Officer) | G | ▲ buy10b5-1 | 150,0000 | — | — | 150,000 | new | +0.14% (now 0.14%) | filing |
| 2026-05-29 | WILSON JAMES N | Director | G | ▼ sell | 892,0560 | — | — | 9,011 | −99% | −0.83% (now <0.01%) | filing |
| 2026-05-29 | WILSON JAMES N | Director | G | ▼ sell | 9,0110 | — | — | 0 | −100% | −<0.01% (now 0%) | filing |
| 2026-05-29 | WILSON JAMES N | Director | G | ▲ buy | 9,0110 | — | — | 1,104,543 | +0.8% | +<0.01% (now 1.0%) | filing |
| 2026-05-29 | Maduck Sean | Officer (See Remarks) | M | ▼ sell10b5-1 | 75,000→ 75,000 Common Stock | — | — | 166,986 | — | — | filing |
| 2026-05-26 | Alton Gregg H | Director | A | ▲ buy | 12,500→ 12,500 Common Stock | — | — | 12,500 | — | — | filing |
| 2026-05-26 | BAKER G LEONARD JR | Director | A | ▲ buy | 12,500→ 12,500 Common Stock | — | — | 12,500 | — | — | filing |
| 2026-05-26 | Park Kimberly | Director | A | ▲ buy | 12,500→ 12,500 Common Stock | — | — | 12,500 | — | — | filing |
| 2026-05-26 | MAHONEY DAVID L | Director | A | ▲ buy | 12,500→ 12,500 Common Stock | — | — | 12,500 | — | — | filing |
| 2026-05-26 | Murray Joshua M. | Director | A | ▲ buy | 12,500→ 12,500 Common Stock | — | — | 12,500 | — | — | filing |
| 2026-05-26 | Swisher Daniel N JR | Director | A | ▲ buy | 12,500→ 12,500 Common Stock | — | — | 12,500 | — | — | filing |
| 2026-05-26 | WILSON JAMES N | Director | A | ▲ buy | 12,500→ 12,500 Common Stock | — | — | 12,500 | — | — | filing |
| 2026-05-15 | Robb Gary Charles | Officer (Chief Business Officer) | G | ▼ sell | 5,3000 | — | — | 24,487 | −18% | −<0.01% (now 0.02%) | filing |
| 2026-05-15 | Robb Gary Charles | Officer (Chief Business Officer) | G | ▲ buy | 1,0000 | — | — | 12,571 | +9% | +<0.01% (now 0.01%) | filing |
| 2026-05-15 | Robb Gary Charles | Officer (Chief Business Officer) | G | ▲ buy | 1,0000 | — | — | 12,571 | +9% | +<0.01% (now 0.01%) | filing |
| 2026-05-07 | Guyer William | Officer (Chief Development Officer) | M | ▼ sell10b5-1 | 20,000→ 20,000 Common Stock | — | — | 170,000 | — | — | filing |
| 2026-04-24 | WILSON JAMES N | Director | G | ▼ sell | 2,0000 | — | — | 1,095,532 | −0.2% | −<0.01% (now 1.0%) | filing |
| 2026-04-08 | WILSON JAMES N | Director | G | ▼ sell | 5,0000 | — | — | 1,097,532 | −0.5% | −<0.01% (now 1.0%) | filing |
| 2026-04-08 | Guyer William | Officer (Chief Development Officer) | M | ▼ sell10b5-1 | 20,000→ 20,000 Common Stock | — | — | 190,000 | — | — | filing |
| 2026-03-24 | Guyer William | Officer (Chief Development Officer) | M | ▼ sell10b5-1 | 11,767→ 11,767 Common Stock | — | — | 210,000 | — | — | filing |
| 2026-03-24 | WILSON JAMES N | Director | G | ▼ sell | 4,0000 | — | — | 1,102,532 | −0.4% | −<0.01% (now 1.0%) | filing |
Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.